Urology · Coral Springs, FL
NPI
1598792848
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1725 N University Dr, Suite 400
Coral Springs, FL, 33071
Phone (954) 752-3166
Groups this clinician bills Medicare through
Medicare paid, 2024
$295K
9,512 services
Medicare patients, 2024
544
Average age 76
Drug cost, 2024
$823K
4,273 prescriptions
Company payments, 2025
$1,941
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dawn M Scarzella was code J0585 (injection, onabotulinumtoxina, 1 unit), 4,576 times for 21 patients. In total Dawn M Scarzella billed 9,512 services in 60 codes, and Medicare paid $295K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 4,576 | 21 | $4.98 | $23K |
| 81002 Clinical Chemistry | Office | 1,096 | 511 | $3.39 | $3,717 |
| 51798 Ultrasound - Nonspecific | Office | 1,049 | 505 | $9.10 | $9,547 |
| 99214 Office E&M - Established | Office | 583 | 331 | $96.68 | $56K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 575 | 338 | $14.07 | $8,089 |
| 99213 Office E&M - Established | Office | 540 | 334 | $75.45 | $41K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 240 | 231 | $88.03 | $21K |
| 99204 Office E&M - New | Office | 129 | 129 | $128.55 | $17K |
| 52281 Calculus Removal - Urinary | Office | 114 | 100 | $271.56 | $31K |
| 52000 Cystourethroscopy | Office | 64 | 58 | $194.75 | $12K |
| 52214 Cystourethroscopy | Office | 42 | 33 | $634.12 | $27K |
| 52287 Cystourethroscopy | Office | 33 | 22 | $137.43 | $4,535 |
| 51784 Neurologic | Office | 26 | 25 | $25.89 | $673 |
| 51741 Test - Miscellaneous | Office | 25 | 25 | $6.17 | $154 |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 22 | 21 | $70.90 | $1,560 |
By year: 2022 $308K for 9,576 services; 2023 $297K for 9,736 services; 2024 $295K for 9,512 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,096 | 511 | $3.39 | $3,717 |
Medicare prescription drug claims, 2024
In 2024, the drug Dawn M Scarzella prescribed most often to Medicare patients was Methenamine Hippurate, with 475 prescriptions and refills. In total Dawn M Scarzella wrote 4,273 Medicare prescriptions that cost $823K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methenamine Hippurate Generic | 475 | 876 | 162 | $33K |
| Solifenacin Succinate Generic | 362 | 773 | 124 | $13K |
| Cephalexin Generic | 321 | 403 | 214 | $1,751 |
| Myrbetriq Mirabegron | 289 | 511 | 83 | $223K |
| Cefdinir Generic | 276 | 276 | 196 | $4,856 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 276 | 327 | 173 | $4,493 |
| Gemtesa Vibegron | 229 | 427 | 68 | $198K |
| Ciprofloxacin Hcl Generic | 222 | 222 | 162 | $1,104 |
| Tamsulosin Hcl Generic | 195 | 519 | 70 | $3,251 |
| Amoxicillin Generic | 150 | 156 | 112 | $238 |
| Terconazole Generic | 113 | 115 | 71 | $2,957 |
| Fluconazole Generic | 106 | 106 | 76 | $556 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 99 | 265 | 38 | $2,931 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 88 | 88 | 58 | $805 |
| Finasteride Generic | 86 | 218 | 32 | $1,032 |
Brand drugs: - claims; generic drugs: 3,528 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dawn M Scarzella $1,941 ($1,941 in general payments such as food, travel and fees) from 26 companies. The largest payer was Janssen Biotech, Inc. with $228.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 15 | $228 |
| Sumitomo Pharma America, Inc. 4506.T | 19 | $219 |
| Endo USA, Inc. | 9 | $213 |
| Myriad Genetic Laboratories, Inc. MYGN | 10 | $161 |
| Procept Biorobotics Corporation PRCT | 1 | $131 |
| Abbvie Inc. ABBV | 5 | $113 |
| Ferring Pharmaceuticals Inc. | 5 | $83.53 |
| Tolmar, Inc. | 4 | $81.1 |
| Becton, Dickinson and Company BDX | 1 | $71.22 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $69.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.